CD3+ CD4+ and CD3+ CD8+ Lymphocyte Subgroups and their Surface Receptors NKG2D and NKG2A in Patients with Non-small Cell Lung Cancer |
Yu, Da-Ping
(Second Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University)
Han, Yi (Second Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University) Zhao, Qiu-Yue (Second Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University) Liu, Zhi-Dong (Second Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University) |
1 | Wang WJ1, Tao Z, Gu W, et al (2013). Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer. Asian Pac J Cancer Prev, 14, 4671-3. DOI ScienceOn |
2 | Park MJ, Bae JH, Chung JS, et al (2011). Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy. Immunol Invest, 40, 367-82. DOI ScienceOn |
3 | Remark R, Alifano M, Cremer I, et al (2013). Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Clin Cancer Res, 19, 4079-91. DOI ScienceOn |
4 | Sanchez de, Cos Escuin J (2014). Diagnosis and Treatment of Neuroendocrine Lung Tumors. Arch Bronconeumol, [Epub ahead of print]. |
5 | Wrobel P, Shojaei H, Schittek B, et al (2007). Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptorversus NKG2D-dependent recognition. Scand J Immunol, 66, 320-8. DOI ScienceOn |
6 | Xia YH, Wang ZM, Chen RX, et al (2013). T-cell apoptosis induced by intratumoral activated hepatic stellate cells is associated with lung metastasis in hepatocellular carcinoma. Oncol Rep, 30, 1175-84. |
7 | Xiao ZM, Wang AM, Wang XY, et al (2013). A study on the inhibitory effect of Solanum lyratum Thunb extract on Lewis lung carcinoma lines. Afr J Tradit Complement Altern Med, 10, 444-8. DOI |
8 | Zhao Y, Yu D, Wu H, et al (2014). Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo. Int J Oncol, 44, 451-8. |
9 | Iyengar P, Gerber DE (2013). Locally advanced lung cancer: an optimal setting for vaccines and other immunotherapies. Cancer J, 19, 247-62. DOI |
10 | Deng W, Long L, Li JL, et al (2014). Mortality of major cancers in Guangxi, China: sex, age and geographical differences from 1971 and 2005. Asian Pac J Cancer Prev, 15, 1567-74. DOI ScienceOn |
11 | Huang XE, Tian GY, Cao J, et al (2013). Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 6663-7. DOI ScienceOn |
12 | Kim JL, Cho KH, Park EC, et al (2014). A single measure of cancer burden combining incidence with mortality rates for worldwide application. Asian Pac J Cancer Prev, 15, 433-9. DOI ScienceOn |
13 | Kuhn S, Hyde EJ, Yang J, et al (2013). Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents. J Immunol, 191, 1984-92. DOI ScienceOn |
14 | Liu G, Lu S, Wang X, et al (2013). Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis. J Clin Invest, 123, 4410-22. DOI ScienceOn |
15 | Liu J, Yang XL, Li A, et al (2014). Epidemiological patterns of cancer incidence in Southern China: based on 6 populationbased cancer registries. Asian Pac J Cancer Prev, 15, 1471-5. DOI ScienceOn |
16 | Liu J, Hau E, Links M, et al (2014). Adenoid cystic carcinoma of the lung: Response to tamoxifen after chemoradiation. Asia Pac J Clin Oncol, [Epub ahead of print]. |
17 | Ganesan AP, Johansson M, Ruffell B, et al (2013). Tumorinfiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma. J Immunol, 191, 2009-17. DOI ScienceOn |
18 | Mamlouk S, Kalucka J, Singh RP, et al (2014). Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development. Int J Cancer, 134, 849-58. DOI ScienceOn |